Member Info for Noshortsallowed

Looks like the 200DMA resistance line is now becoming support. I'm just gutted I've not got any dry powder to get some more at these ridiculously low levels before it breaks out properly.

GLA

https://www.prnewswire.com/news-releases/market-forecasts-for-immuno-oncology-diagnostics-2023-sector-represents-a-revolution-in-cancer-therapy-301726727.html

Future looks bright, we're listed in the appendix.

GLA

We've pushed through some resistance lines over the past couple of weeks which have known clearly become support lines. So from last Thursday to this Tuesday 9 DMA was a strong support @ 1.52-1.59. Yesterday 50 DMA gave us some strong support @ 1.61. Today 100 DMA is showing to be giving us support @ 1.64.

Only one daily resistance line to overcome 200DMA @ 1.72 this has surely got to go today or tomorrow.

GLA

@CorePath Laboratories. Two Flow Cytometry Technologists level I and level II required. Could this be to help develop our test I wonder?

GLA

https://tracxn.com/d/trending-themes/Startups-in-Lung-Cancer-IVD-Tests

Looks like there's going to be a push to break through the 200 DMA this week which is ~1.73p.

GLA

https://www.geneonline.com/jpm23-more-deals-defining-jp-morgan-healthcare-conference-2023-day-two/

https://www.evaluate.com/node/18511/amp

These shares are not on the market until 8.00 a.m. tomorrow morning. However, fully agree get once they are cleared we're off to the races.

GLA

Only 8 trading sessions left this calendar year.

GLA

A single share un-crossed trade this morning. Are we to expect an RNS of significance imminently?

GLA

Correction bearish indicator, apologies.

Looks like a head and shoulders chart pattern on the 6 month chart- bullish indicator unfortunately. Now with the extra shares in circulation if we would to drop to same all time low mcap we're looking at SP 1p rather than 1.3p we seen back in July. Fingers crossed I'm totally wrong and the opposite happens or we get an RNS which gets the rocket fired up.

GLA

Major news and inflection point to come before the end of this calendar year, not long to wait now.

GLA

NathanR999 I think you are right that over time, once the test is established that the test will be significantly cheaper once economies of scale kick in. However, initially I think we can take that the price of the test is going to be in and around the £100 mark.

GLA

Think we've got a good chance of finishing the week above the 200 DMA, currently @ 1.8964 pence. If we can finish the week strong and above the 200 DMA think we can go on a good bull run.

GLA

One step at a time wj but if everything falls into place for CIZ I think we're all going to be very happy with our investments, even Widglide lol.

GLA

Does look anything like this wj40?

£100 per test. 10% royalty China. 15% Royalty USA. 30,000,000 tests per year needed in China alone.

30,000,000 × £100 = £3,000,000,000.
10% = £300,000,000 in revenue for CIZ.
£300,000,000 ÷ 340,000,000 shares in issue = SP £0.88.
Using a modest P/E of say 2.5 gives a SP of £2.20.
Again, this is just China.

Will we see another RNS drop in the not so distant future regarding Corepath and the US.

GLA

2 out of the last 4 trading sessions has opened up as a gap up on the chart. Yet another indicator of a trend reversal to a more positive bullish trend.

GLA